DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - White Blood Cell Count Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with White Blood Cell Count Decreased (93)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 93   Next >>

Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient:

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Confusional State, Tinnitus, Pain, Chills, Anaemia, Hot Flush, Fatigue, Diarrhoea, Depression, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Ribasphere
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-27

Other drugs received by patient: Prograf



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk, qw
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-07-25

Ribavirin
    Dosage: unk, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-07-25



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Nausea, RED Blood Cell Count Decreased, Asthenia, Somnolence

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-23

Rebetol
    Dosage: 200 mg, bid
    Administration route: Oral

Rebetol
    Dosage: 400 mg,
    Indication: Hepatitis C
    Start date: 2012-02-23

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-03-22



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased

Drug(s) suspected as cause:
Interferon Beta NOS
    Dosage: 3 million iu, bid,6 days a week
    Indication: Hepatitis C
    Start date: 2011-01-21
    End date: 2011-02-03

PEG-Intron
    Dosage: 100 ?g, qw
    Indication: Hepatitis C
    Start date: 2011-02-04

Ribavirin
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-21
    End date: 2011-02-03

Ribavirin
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2011-02-04

Other drugs received by patient: Candesartan Cilexetil; Lorfenamin; Norvasc; Urso 250; Lorfenamin



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-09-08
    End date: 2012-08-09

Ribavirin
    Dosage: unk unk, unknown
    Start date: 2011-09-08
    End date: 2012-08-09

Other drugs received by patient: Telaprevir



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient:

Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

PEG-Intron
    Dosage: unk unk, unknown
    Start date: 2011-08-17
    End date: 2012-04-03

PEG-Intron
    Dosage: unk unk, unknown
    End date: 2009-10-07

PEG-Intron
    Dosage: 0.4 ?g, unknown

PEG-Intron
    Dosage: 0.3 ?g, unknown

Ribavirin
    Dosage: unk unk, unknown
    End date: 2009-10-07

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

Ribavirin
    Dosage: 200 mg, qd

Ribavirin
    Dosage: unk unk, qd

Ribavirin
    Dosage: unk unk, qd
    Start date: 2011-08-17
    End date: 2012-04-03

Ribavirin

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2011-09-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2011-09-14

Other drugs received by patient: Epoetin Alfa



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Dehydration, Food Craving, Blood Count Abnormal, Dizziness

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-24

Ribavirin
    Dosage: unk unk, bid
    Indication: Hepatitis C
    Start date: 2012-02-24

Ribavirin
    Dosage: unk unk, qd



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-14

Patient:

Reactions: White Blood Cell Count Decreased, Depression

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-16

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-07-13
    End date: 2012-07-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-12

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-14

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Alopecia, Dehydration, Pancytopenia, Neutropenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, unk
    Start date: 2011-12-27

Ribavirin
    Dosage: 1200 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-25

Other drugs received by patient: Rosuvastatin; Ramipril; Glucazide; Oxazepam; Premarin; Metformin HCL



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-13

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-06-26

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08

Rebetol
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-02

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-05-29

Telavic
    Administration route: Oral
    Start date: 2012-05-30
    End date: 2012-06-25

Other drugs received by patient: Xyzal; Lansoprazole; Cernilton; Flivas; Selbex



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-10

Patient:

Reactions: White Blood Cell Count Decreased, Dysgeusia, Weight Decreased, Vomiting, Nausea, Dehydration, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-07-01

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-07-01



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Blood Creatinine Increased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-03

Rebetol
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-07-03

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-05-17

Rebetol
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-05-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-11

Other drugs received by patient: Gasmotin



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Basedow's Disease, Weight Decreased, Pruritus, Diabetes Mellitus, Rectal Haemorrhage, Blood Count Abnormal, Appetite Disorder, RED Blood Cell Count Decreased, Anorectal Discomfort, Oedema Peripheral, White Blood Cell Count Decreased, Faeces Hard, Dysgeusia, Mental Impairment, Diarrhoea, Disease Recurrence, Alopecia, Platelet Count Decreased, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-01-04

Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2005-04-01
    End date: 2006-03-03

Pegasys
    Dosage: unk
    Start date: 2012-03-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-01-04

Rebetol
    Dosage: 3 df, qd
    Start date: 2012-03-22

Rebetol
    Dosage: unk
    Start date: 2005-04-01
    End date: 2006-03-03

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-19



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-07

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Orthostatic Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-04-06

PEG-Intron
    Dosage: 1. microgram per kilogram per week
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-06-29

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-16
    End date: 2012-03-19

Rebetol
    Dosage: 200mg/twice a week on monday and friday
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-05

Rebetol
    Dosage: 200 mg, once
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-04-26

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-03-01

Rebetol
    Dosage: 200mg/every other day
    Administration route: Oral
    Start date: 2012-04-06
    End date: 2012-04-19

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-04-06

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-04-27
    End date: 2012-06-14

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-29

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-15

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-04-06

Other drugs received by patient: Hirudoid; Primperan TAB; Loxonin; Levofloxacin; Zolpidem; Hirudoid; Allopurinol; Nexium



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: White Blood Cell Count Decreased, Dehydration, Paranasal Sinus Hypersecretion, Aptyalism, Influenza Like Illness

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 rp, unk

Ribavirin
    Dosage: 1200/day

Victrelis
    Dosage: 800 mg, tid (every 7-9 hours) with food
    Administration route: Oral

Other drugs received by patient: Tylenol (Caplet); Vitamins (Unspecified); Aspirin; Benazepril Hydrochloride



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-07

Patient:

Reactions: Weight Decreased, White Blood Cell Count Decreased, Injection Site Erythema, Fatigue, Anaemia, Dizziness

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Start date: 2012-05-08

Victrelis
    Dosage: 4 unk, tid
    Start date: 2012-04-24

Other drugs received by patient: Ribasphere



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: White Blood Cell Count Decreased, Pruritus, Impaired Healing, Tooth Abscess, Skin Lesion, Tooth Extraction, Platelet Count Decreased, Memory Impairment

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-04

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-04

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-02



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: White Blood Cell Count Decreased, Weight Decreased, Skin Injury, Vomiting, Drug Ineffective, Tooth Extraction, Tooth Infection, Headache, Haematemesis, Pain in JAW

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-05

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-05

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-03
    End date: 2012-07-06



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-04

Patient:

Reactions: White Blood Cell Count Decreased, Fatigue, Impatience, Dizziness, Thirst, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-20

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-20



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-04

Patient:

Reactions: White Blood Cell Count Decreased, Dysgeusia, Throat Irritation, Nausea, Dyspepsia, Emotional Disorder, Gastrooesophageal Reflux Disease, Crying

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-19

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-19

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-19



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-03

Patient:

Reactions: White Blood Cell Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-11

Ribasphere



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-02

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Dysgeusia, Malaise, Haemolytic Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-22

PEG-Intron
    Dosage: 1.5mcg/kg/week

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-05-09

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-05-11

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-22
    End date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-05-09

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-22
    End date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-22

Other drugs received by patient: Marzulene-S; Nexium; Diovan; Azunol (Sodium Gualenate); Adalat CC; Mucosta



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: Drug Eruption, White Blood Cell Count Decreased, Depressive Symptom, Pancytopenia, Dysgeusia, Haemoglobin Decreased, Malaise, Diarrhoea, Epistaxis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100mcg/week
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-24

Rebetol
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-05

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-05

Other drugs received by patient: Marzulene-S; Mucosta; Urso 250; Famotidine



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient:

Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qd

Pegasys
    Dosage: 180mcg,once a week

Rebetol
    Dosage: 1200 mg, qd

Victrelis
    Dosage: 200mg,4tablets,three times a day

Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: White Blood Cell Count Decreased, Pruritus, Pain, Platelet Count Decreased, Rash, Blister

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-19

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-19

Other drugs received by patient: Telaprevir



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: White Blood Cell Count Decreased, Haemoglobin Decreased, RED Blood Cell Count Decreased, Blood Albumin Decreased, Platelet Count Decreased, Protein Total Decreased, Neutrophil Count Decreased

Drug(s) suspected as cause:
Interferon Beta NOS
    Indication: Hepatitis C
    Start date: 2010-08-16
    End date: 2010-08-18

Interferon Beta NOS
    Start date: 2010-08-23
    End date: 2010-09-06

Interferon Beta NOS
    Start date: 2010-09-21
    End date: 2010-10-12

Interferon Beta NOS
    Start date: 2010-08-19
    End date: 2010-08-21

Interferon Beta NOS
    Start date: 2010-09-07
    End date: 2010-09-18

PEG-Intron
    Dosage: unk unk, qw
    Indication: Hepatitis C
    Start date: 2010-10-15
    End date: 2011-02-04

Rebetol
    Administration route: Oral
    Start date: 2010-10-01
    End date: 2010-10-14

Rebetol
    Dosage: 400 mg in the morning, 200 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-08-16
    End date: 2010-09-30

Rebetol
    Administration route: Oral
    Start date: 2010-10-15

Other drugs received by patient: Loxonin



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-06-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-06-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-08
    End date: 2012-06-29



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012